China Mesalazine Market Report & Forecast 2021-2027

Publisher Name :
Date: 26-Aug-2021
No. of pages: 108
Inquire Before Buying

This report contains market size and forecasts of Mesalazine in China, including the following market information:

China Mesalazine Market Revenue, 2016-2021, 2022-2027, ($ millions)

China Mesalazine Market Sales, 2016-2021, 2022-2027, (Ton)

China top five Mesalazine companies in 2020 (%)

The global Mesalazine market size is expected to growth from US$ 142.4 million in 2020 to US$ 189 million by 2027; it is expected to grow at a CAGR of 4.1% during 2021-2027.

The China Mesalazine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Mesalazine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China Mesalazine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Ton)

China Mesalazine Market Segment Percentages, By Type, 2020 (%)

- Purity ? 97 %

- Purity ? 98 %

- Purity ? 99 %

China Mesalazine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Ton)

China Mesalazine Market Segment Percentages, By Application, 2020 (%)

- Tablets

- Capsules

- Pellet and Granule

- Suppository

- Enema

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mesalazine revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Mesalazine revenues share in China market, 2020 (%)

Key companies Mesalazine sales in China market, 2016-2021 (Estimated), (Ton)

Key companies Mesalazine sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- PharmaZell

- Syntese A/S

- Cambrex Corporation

- Divis Laboratories

- Chemi SpA

- Ipca Laboratories

- Hangzhou Brother

- Lianyungang Fengheng Biopharm

- Lasa Loboratory

- Corden Pharma Bergamo

- Erregierre SpA

- CTX Lifescience

- Ishita Active Pharma Ingredients

- YC Biotech (Jiangsu)

- Xinxiang Tianfeng Fine Chemical

China Mesalazine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Mesalazine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Mesalazine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Mesalazine Overall Market Size
2.1 China Mesalazine Market Size: 2021 VS 2027
2.2 China Mesalazine Revenue, Prospects & Forecasts: 2016-2027
2.3 China Mesalazine Sales: 2016-2027
3 Company Landscape
3.1 Top Mesalazine Players in China Market
3.2 Top China Mesalazine Companies Ranked by Revenue
3.3 China Mesalazine Revenue by Companies
3.4 China Mesalazine Sales by Companies
3.5 China Mesalazine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Mesalazine Companies in China Market, by Revenue in 2020
3.7 Manufacturers Mesalazine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mesalazine Players in China Market
3.8.1 List of Tier 1 Mesalazine Companies in China
3.8.2 List of Tier 2 and Tier 3 Mesalazine Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Mesalazine Market Size Markets, 2021 & 2027
4.1.2 Purity ? 97 %
4.1.3 Purity ? 98 %
4.1.4 Purity ? 99 %
4.2 By Type - China Mesalazine Revenue & Forecasts
4.2.1 By Type - China Mesalazine Revenue, 2016-2021
4.2.2 By Type - China Mesalazine Revenue, 2022-2027
4.2.3 By Type - China Mesalazine Revenue Market Share, 2016-2027
4.3 By Type - China Mesalazine Sales & Forecasts
4.3.1 By Type - China Mesalazine Sales, 2016-2021
4.3.2 By Type - China Mesalazine Sales, 2022-2027
4.3.3 By Type - China Mesalazine Sales Market Share, 2016-2027
4.4 By Type - China Mesalazine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Mesalazine Market Size, 2021 & 2027
5.1.2 Tablets
5.1.3 Capsules
5.1.4 Pellet and Granule
5.1.5 Suppository
5.1.6 Enema
5.1.7 Others
5.2 By Application - China Mesalazine Revenue & Forecasts
5.2.1 By Application - China Mesalazine Revenue, 2016-2021
5.2.2 By Application - China Mesalazine Revenue, 2022-2027
5.2.3 By Application - China Mesalazine Revenue Market Share, 2016-2027
5.3 By Application - China Mesalazine Sales & Forecasts
5.3.1 By Application - China Mesalazine Sales, 2016-2021
5.3.2 By Application - China Mesalazine Sales, 2022-2027
5.3.3 By Application - China Mesalazine Sales Market Share, 2016-2027
5.4 By Application - China Mesalazine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 PharmaZell
6.1.1 PharmaZell Corporation Information
6.1.2 PharmaZell Overview
6.1.3 PharmaZell Mesalazine Sales and Revenue in China Market (2016-2021)
6.1.4 PharmaZell Mesalazine Product Description
6.1.5 PharmaZell Recent Developments
6.2 Syntese A/S
6.2.1 Syntese A/S Corporation Information
6.2.2 Syntese A/S Overview
6.2.3 Syntese A/S Mesalazine Sales and Revenue in China Market (2016-2021)
6.2.4 Syntese A/S Mesalazine Product Description
6.2.5 Syntese A/S Recent Developments
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Corporation Information
6.3.2 Cambrex Corporation Overview
6.3.3 Cambrex Corporation Mesalazine Sales and Revenue in China Market (2016-2021)
6.3.4 Cambrex Corporation Mesalazine Product Description
6.3.5 Cambrex Corporation Recent Developments
6.4 Divis Laboratories
6.4.1 Divis Laboratories Corporation Information
6.4.2 Divis Laboratories Overview
6.4.3 Divis Laboratories Mesalazine Sales and Revenue in China Market (2016-2021)
6.4.4 Divis Laboratories Mesalazine Product Description
6.4.5 Divis Laboratories Recent Developments
6.5 Chemi SpA
6.5.1 Chemi SpA Corporation Information
6.5.2 Chemi SpA Overview
6.5.3 Chemi SpA Mesalazine Sales and Revenue in China Market (2016-2021)
6.5.4 Chemi SpA Mesalazine Product Description
6.5.5 Chemi SpA Recent Developments
6.6 Ipca Laboratories
6.6.1 Ipca Laboratories Corporation Information
6.6.2 Ipca Laboratories Overview
6.6.3 Ipca Laboratories Mesalazine Sales and Revenue in China Market (2016-2021)
6.6.4 Ipca Laboratories Mesalazine Product Description
6.6.5 Ipca Laboratories Recent Developments
6.7 Hangzhou Brother
6.7.1 Hangzhou Brother Corporation Information
6.7.2 Hangzhou Brother Overview
6.7.3 Hangzhou Brother Mesalazine Sales and Revenue in China Market (2016-2021)
6.7.4 Hangzhou Brother Mesalazine Product Description
6.7.5 Hangzhou Brother Recent Developments
6.8 Lianyungang Fengheng Biopharm
6.8.1 Lianyungang Fengheng Biopharm Corporation Information
6.8.2 Lianyungang Fengheng Biopharm Overview
6.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales and Revenue in China Market (2016-2021)
6.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Description
6.8.5 Lianyungang Fengheng Biopharm Recent Developments
6.9 Lasa Loboratory
6.9.1 Lasa Loboratory Corporation Information
6.9.2 Lasa Loboratory Overview
6.9.3 Lasa Loboratory Mesalazine Sales and Revenue in China Market (2016-2021)
6.9.4 Lasa Loboratory Mesalazine Product Description
6.9.5 Lasa Loboratory Recent Developments
6.10 Corden Pharma Bergamo
6.10.1 Corden Pharma Bergamo Corporation Information
6.10.2 Corden Pharma Bergamo Overview
6.10.3 Corden Pharma Bergamo Mesalazine Sales and Revenue in China Market (2016-2021)
6.10.4 Corden Pharma Bergamo Mesalazine Product Description
6.10.5 Corden Pharma Bergamo Recent Developments
6.11 Erregierre SpA
6.11.1 Erregierre SpA Corporation Information
6.11.2 Erregierre SpA Overview
6.11.3 Erregierre SpA Mesalazine Sales and Revenue in China Market (2016-2021)
6.11.4 Erregierre SpA Mesalazine Product Description
6.11.5 Erregierre SpA Recent Developments
6.12 CTX Lifescience
6.12.1 CTX Lifescience Corporation Information
6.12.2 CTX Lifescience Overview
6.12.3 CTX Lifescience Mesalazine Sales and Revenue in China Market (2016-2021)
6.12.4 CTX Lifescience Mesalazine Product Description
6.12.5 CTX Lifescience Recent Developments
6.13 Ishita Active Pharma Ingredients
6.13.1 Ishita Active Pharma Ingredients Corporation Information
6.13.2 Ishita Active Pharma Ingredients Overview
6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales and Revenue in China Market (2016-2021)
6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Description
6.13.5 Ishita Active Pharma Ingredients Recent Developments
6.14 YC Biotech (Jiangsu)
6.14.1 YC Biotech (Jiangsu) Corporation Information
6.14.2 YC Biotech (Jiangsu) Overview
6.14.3 YC Biotech (Jiangsu) Mesalazine Sales and Revenue in China Market (2016-2021)
6.14.4 YC Biotech (Jiangsu) Mesalazine Product Description
6.14.5 YC Biotech (Jiangsu) Recent Developments
6.15 Xinxiang Tianfeng Fine Chemical
6.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information
6.15.2 Xinxiang Tianfeng Fine Chemical Overview
6.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales and Revenue in China Market (2016-2021)
6.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Description
6.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments
7 China Mesalazine Production Capacity, Analysis
7.1 China Mesalazine Production Capacity, 2016-2027
7.2 Mesalazine Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Mesalazine Supply Chain Analysis
9.1 Mesalazine Industry Value Chain
9.2 Mesalazine Upstream Market
9.3 Mesalazine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Mesalazine Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Mesalazine in China Market
Table 2. Top Mesalazine Players in China Market, Ranking by Revenue (2019)
Table 3. China Mesalazine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Mesalazine Revenue Share by Companies, 2016-2021
Table 5. China Mesalazine Sales by Companies, (Ton), 2016-2021
Table 6. China Mesalazine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Mesalazine Price (2016-2021) & (US$/Kg)
Table 8. Manufacturers Mesalazine Product Type
Table 9. List of Tier 1 Mesalazine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Mesalazine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Purity ? 97 %
Table 12. Major Manufacturers of Purity ? 98 %
Table 13. By Type - China Mesalazine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Mesalazine Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Mesalazine Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Mesalazine Sales (Ton), 2016-2021
Table 17. By Type - China Mesalazine Sales (Ton), 2022-2027
Table 18. By Application - China Mesalazine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Mesalazine Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Mesalazine Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Mesalazine Sales (Ton), 2016-2021
Table 22. By Application - China Mesalazine Sales (Ton), 2022-2027
Table 23. PharmaZell Corporation Information
Table 24. PharmaZell Description and Major Businesses
Table 25. PharmaZell Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 26. PharmaZell Mesalazine Product
Table 27. PharmaZell Recent Developments
Table 28. Syntese A/S Corporation Information
Table 29. Syntese A/S Description and Major Businesses
Table 30. Syntese A/S Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 31. Syntese A/S Mesalazine Product
Table 32. Syntese A/S Recent Developments
Table 33. Cambrex Corporation Corporation Information
Table 34. Cambrex Corporation Description and Major Businesses
Table 35. Cambrex Corporation Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 36. Cambrex Corporation Mesalazine Product
Table 37. Cambrex Corporation Recent Developments
Table 38. Divis Laboratories Corporation Information
Table 39. Divis Laboratories Description and Major Businesses
Table 40. Divis Laboratories Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 41. Divis Laboratories Mesalazine Product
Table 42. Divis Laboratories Recent Developments
Table 43. Chemi SpA Corporation Information
Table 44. Chemi SpA Description and Major Businesses
Table 45. Chemi SpA Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 46. Chemi SpA Mesalazine Product
Table 47. Chemi SpA Recent Developments
Table 48. Ipca Laboratories Corporation Information
Table 49. Ipca Laboratories Description and Major Businesses
Table 50. Ipca Laboratories Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 51. Ipca Laboratories Mesalazine Product
Table 52. Ipca Laboratories Recent Developments
Table 53. Hangzhou Brother Corporation Information
Table 54. Hangzhou Brother Description and Major Businesses
Table 55. Hangzhou Brother Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 56. Hangzhou Brother Mesalazine Product
Table 57. Hangzhou Brother Recent Developments
Table 58. Lianyungang Fengheng Biopharm Corporation Information
Table 59. Lianyungang Fengheng Biopharm Description and Major Businesses
Table 60. Lianyungang Fengheng Biopharm Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 61. Lianyungang Fengheng Biopharm Mesalazine Product
Table 62. Lianyungang Fengheng Biopharm Recent Developments
Table 63. Lasa Loboratory Corporation Information
Table 64. Lasa Loboratory Description and Major Businesses
Table 65. Lasa Loboratory Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 66. Lasa Loboratory Mesalazine Product
Table 67. Lasa Loboratory Recent Developments
Table 68. Corden Pharma Bergamo Corporation Information
Table 69. Corden Pharma Bergamo Description and Major Businesses
Table 70. Corden Pharma Bergamo Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 71. Corden Pharma Bergamo Mesalazine Product
Table 72. Corden Pharma Bergamo Recent Developments
Table 73. Erregierre SpA Corporation Information
Table 74. Erregierre SpA Description and Major Businesses
Table 75. Erregierre SpA Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 76. Erregierre SpA Mesalazine Product
Table 77. Erregierre SpA Recent Developments
Table 78. CTX Lifescience Corporation Information
Table 79. CTX Lifescience Description and Major Businesses
Table 80. CTX Lifescience Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 81. CTX Lifescience Mesalazine Product
Table 82. CTX Lifescience Recent Developments
Table 83. Ishita Active Pharma Ingredients Corporation Information
Table 84. Ishita Active Pharma Ingredients Description and Major Businesses
Table 85. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 86. Ishita Active Pharma Ingredients Mesalazine Product
Table 87. Ishita Active Pharma Ingredients Recent Developments
Table 88. YC Biotech (Jiangsu) Corporation Information
Table 89. YC Biotech (Jiangsu) Description and Major Businesses
Table 90. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 91. YC Biotech (Jiangsu) Mesalazine Product
Table 92. YC Biotech (Jiangsu) Recent Developments
Table 93. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 94. Xinxiang Tianfeng Fine Chemical Description and Major Businesses
Table 95. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue (US$, Mn) and Gross Margin (US$/Kg) (2016-2021)
Table 96. Xinxiang Tianfeng Fine Chemical Mesalazine Product
Table 97. Xinxiang Tianfeng Fine Chemical Recent Developments
Table 98. Mesalazine Production Capacity (Ton) of Key Manufacturers in China Market, 2019-2021 (Ton)
Table 99. China Mesalazine Capacity Market Share of Key Manufacturers, 2019-2021
Table 100. Mesalazine Market Opportunities & Trends in China Market
Table 101. Mesalazine Market Drivers in China Market
Table 102. Mesalazine Market Restraints in China Market
Table 103. Mesalazine Raw Materials
Table 104. Mesalazine Raw Materials Suppliers in China Market
Table 105. Typical Mesalazine Downstream
Table 106. Mesalazine Downstream Clients in China Market
Table 107. Mesalazine Distributors and Sales Agents in China Market
List of Figures
Figure 1. Mesalazine Product Picture
Figure 2. Mesalazine Segment by Type
Figure 3. Mesalazine Segment by Application
Figure 4. China Mesalazine Market Overview: 2020
Figure 5. China Mesalazine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Mesalazine Revenue, 2016-2027 (US$, Mn)
Figure 7. Mesalazine Sales in China Market: 2016-2027 (Ton)
Figure 8. The Top 3 and 5 Players Market Share by Mesalazine Revenue in 2020
Figure 9. Purity ? 97 % Product Picture
Figure 10. Purity ? 98 % Product Picture
Figure 11. Purity ? 99 % Product Picture
Figure 12. By Type - China Mesalazine Sales Market Share, 2016-2027
Figure 13. By Type - China Mesalazine Revenue Market Share, 2016-2027
Figure 14. By Type - China Mesalazine Price (US$/Kg), 2016-2027
Figure 15. Tablets
Figure 16. Capsules
Figure 17. Pellet and Granule
Figure 18. Suppository
Figure 19. Enema
Figure 20. By Application - China Mesalazine Sales Market Share, 2016-2027
Figure 21. By Application - China Mesalazine Revenue Market Share, 2016-2027
Figure 22. By Application - China Mesalazine Price (US$/Kg), 2016-2027
Figure 23. PharmaZell Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Syntese A/S Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Cambrex Corporation Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Divis Laboratories Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Chemi SpA Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Ipca Laboratories Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Hangzhou Brother Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Lianyungang Fengheng Biopharm Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Lasa Loboratory Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Corden Pharma Bergamo Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Erregierre SpA Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. CTX Lifescience Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Ishita Active Pharma Ingredients Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. YC Biotech (Jiangsu) Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Xinxiang Tianfeng Fine Chemical Mesalazine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. China Mesalazine Production Capacity (Ton), 2016-2027
Figure 39. Mesalazine Industry Value Chain
Figure 40. Marketing Channels
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs